Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof

The present invention is directed to substituted azoanthracene derivatives or pharmaceutically acceptable salts thereof that modulate the human GLP-1 receptor and that may be useful in the treatment of diseases, disorders, or conditions in which modulation of the human GLP-1 receptor is beneficial,...

Full description

Saved in:
Bibliographic Details
Main Authors BONDLELA MURALIDHAR, ANDREWS ROBERT CARL, CHRISTEN DANIEL P, FREEMAN JENNIFER L. R, DAVIS STEPHEN THOMAS, BEHME CHRISTOPHER, SANTHOSH KALPATHY, YARRAGUNTA RAVINDRA REDDY, YOKUM THOMAS SCOTT, MJALLI ADNAN M. M, GUZEL MUSTAFA, QUADA JAMES, GOHIMUKKULA DEVI REDDY, POLISETTI DHARMA RAO
Format Patent
LanguageChinese
English
Published 14.03.2012
Subjects
AGRICULTURE
ANIMAL HUSBANDRY
BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES
FISHING
FORESTRY
HUMAN NECESSITIES
HUNTING
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PEST REPELLANTS OR ATTRACTANTS
PLANT GROWTH REGULATORS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF
TRAPPING
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to substituted azoanthracene derivatives or pharmaceutically acceptable salts thereof that modulate the human GLP-1 receptor and that may be useful in the treatment of diseases, disorders, or conditions in which modulation of the human GLP-1 receptor is beneficial, such as diabetes mellitus type 2. The invention is also directed to pharmaceutical compositions comprising these compounds and to the use of these compounds and compositions in the treatment of such diseases, disorders, or conditions in which modulation of the human GLP-1 receptor is beneficial.
Bibliography:Application Number: CN201080015264